Regeneron Pharmaceuticals, Inc. (LON: 0R2M)

Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of 60.06 billion as of December 23, 2024. Its market cap has decreased by -16.37% in one year.

• Market Cap: 60.06B
• Enterprise Value: 47.67B
• Revenue: 10.33B
• Ranking: n/a
• PE Ratio: 17.30
• Stock Price: 709.23

Market Cap Chart

Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 96.12M to 60.06B, an increase of 62,386.44%. That is a compound annual growth rate of 21.95%.

Market Cap History

Date	Market Cap	% Change
Dec 20, 2024	60.06B	-18.09%
Dec 29, 2023	73.33B	14.66%
Dec 30, 2022	63.95B	31.15%
Dec 31, 2021	48.76B	30.57%
Dec 31, 2020	37.35B	20.50%
Dec 31, 2019	30.99B	-2.19%